Cargando…

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae

ZTI-01 (fosfomycin for injection) is a broad-spectrum antibiotic with a novel mechanism of action and is currently under development in the United States for treatment of complicated urinary tract infections. Globally, fosfomycin and polymyxin B are increasingly being used to treat multidrug-resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diep, John K., Sharma, Rajnikant, Ellis-Grosse, Evelyn J., Abboud, Cely S., Rao, Gauri G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786778/ https://www.ncbi.nlm.nih.gov/pubmed/29203494 http://dx.doi.org/10.1128/AAC.01815-17

Ejemplares similares

1367. Clinical Cure in Secondary Efficacy Populations in Patients With Complicated Urinary Tract Infection Treated With ZTI-01 (Fosfomycin for Injection): Findings From the ZEUS Trial
por: Kaye, Keith, et al.
Publicado: (2018)

Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial
por: Kaye, Keith S, et al.
Publicado: (2019)

In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates
por: Ribeiro, Aghata Cardoso da Silva, et al.
Publicado: (2023)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

ZTI-01 Treatment Improves Survival of Animals Infected with Multidrug Resistant Pseudomonas aeruginosa
por: Lawrenz, Matthew B, et al.
Publicado: (2017)

Evaluation Strategies for Triple‐Drug Combinations against Carbapenemase‐Producing Klebsiella Pneumoniae in an In Vitro Hollow‐Fiber Infection Model
por: Garcia, Estefany, et al.
Publicado: (2021)

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2017)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

Emergence of KPC-producing Klebsiella pneumoniae in Italy
por: Fontana, Carla, et al.
Publicado: (2010)

Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases
por: Gomez, Eric, et al.
Publicado: (2011)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae
por: Pitt, Miranda E., et al.
Publicado: (2018)

Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae
por: Hussein, Maytham, et al.
Publicado: (2022)

Management of infections due to KPC-producing Klebsiella pneumoniae
por: Deresinski, Stanley C, et al.
Publicado: (2009)

KPC-producing Klebsiella pneumoniae, finally targeting Turkey
por: Labarca, J, et al.
Publicado: (2014)

Proof‐of‐concept for incorporating mechanistic insights from multi‐omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniae
por: Hanafin, Patrick O., et al.
Publicado: (2023)

First detection of KPC-3-producing Klebsiella pneumoniae in Albania
por: Kostyanev, T., et al.
Publicado: (2015)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
por: Huang, Yanqin, et al.
Publicado: (2021)

The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae
por: Tang, Hung-Jen, et al.
Publicado: (2022)

Identification of Klebsiella pneumoniae that produces β-Lactamase bla(KPC )gene
por: Sá Queiroz, Julio Henrique Ferreira de, et al.
Publicado: (2014)

First clinical case of KPC-3–producing Klebsiella michiganensis in Europe
por: Seiffert, S.N., et al.
Publicado: (2019)

Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study
por: Oliva, A, et al.
Publicado: (2022)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba
por: Quiñones, D, et al.
Publicado: (2014)

Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization
por: Marquez, C, et al.
Publicado: (2014)

KPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil
por: Biberg, Camila Arguelo, et al.
Publicado: (2015)

Complete Genome Sequence of KPC-Producing Klebsiella pneumoniae Strain CAV1193
por: Sheppard, Anna E., et al.
Publicado: (2016)

Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China
por: Liang, Yuying, et al.
Publicado: (2017)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017)

Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media
por: Anwar, Shamsuddin, et al.
Publicado: (2020)

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing Klebsiella pneumoniae in Colombia
por: De La Cadena, Elsa, et al.
Publicado: (2021)

Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013
por: Tseng, I-Ling, et al.
Publicado: (2015)

Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report
por: Arcari, Gabriele, et al.
Publicado: (2022)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
por: Le, Jennifer, et al.
Publicado: (2011)

Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase bla(KPC-2) Gene
por: Cuzon, Gaëlle, et al.
Publicado: (2010)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone
por: Villa, Laura, et al.
Publicado: (2017)

Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases
por: Patrial, Yasmin Coelho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ha0mpb710md52j8jk5la46kk3r